Frequency-domain optical coherence tomographic analysis of plaque microstructures at nonculprit narrowings in patients receiving potent statin therapy

American Journal of Cardiology

Volumn 114, Issue 4, 2014, Pages 549-554

  Kataoka, Yu ^a   Puri, Rishi ^b   Hammadah, Muhammad ^b   Duggal, Bhanu ^b   Uno, Kiyoko ^b   Kapadia, Samir R ^b   Tuzcu, E Murat ^b   Nissen, Steven E ^b   Nicholls, Stephen J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; TRIACYLGLYCEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG DOSE COMPARISON; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FIBROUS CAP THICKNESS; HEART MUSCLE ISCHEMIA; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NONCULPRIT LIPID PLAQUE; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PERCUTANEOUS CORONARY INTERVENTION; PLAQUE MICROSTRUCTURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT DURATION; CORONARY BLOOD VESSEL; FOLLOW UP; METABOLISM; MIDDLE AGED; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; PROCEDURES;

CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPIDS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84905571707     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.05.035     Document Type: Article

References (25)

1. C.P. Cannon, E. Braunwald, C.H. McCabe, D.J. Rader, J.L. Rouleau, R. Belder, S.V. Joyal, K.A. Hill, M.A. Pfeffer, A.M. Skene Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
2. T.R. Pedersen, O. Faergeman, J.J. Kastelein, A.G. Olsson, M.J. Tikkanen, I. Holme, M.L. Larsen, F.S. Bendiksen, C. Lindahl, M. Szarek, J. Tsai Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial JAMA 294 2005 2437 2445
3. J.C. LaRosa, S.M. Grundy, D.D. Waters, C. Shear, P. Barter, J.C. Fruchart, A.M. Gotto, H. Greten, J.J. Kastelein, J. Shepherd, N.K. Wenger Treating to New Targets (TNT) Investigators Intensive lipid lowering with atorvastatin in patients with stable coronary disease N Engl J Med 352 2005 1425 1435
4. S.E. Nissen, S.J. Nicholls, I. Sipahi, P. Libby, J.S. Raichlen, C.M. Ballantyne, J. Davignon, R. Erbel, J.C. Fruchart, J.C. Tardif, P. Schoenhagen, T. Crowe, V. Cain, K. Wolski, M. Goormastic, E.M. Tuzcu ASTEROID Investigators Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 2006 1556 1565
5. S.J. Nicholls, C.M. Ballantyne, P.J. Barter, M.J. Chapman, R.M. Erbel, P. Libby, J.S. Raichlen, K. Uno, M. Borgman, K. Wolski, and S.E. Nissen Effect of two intensive statin regimens on progression of coronary disease N Engl J Med 365 2011 2078 2087
6. G.K. Sukhova, J.K. Williams, and P. Libby Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol Arterioscler Thromb Vasc Biol 22 2002 1452 1458
7. M. Spite, and C.N. Serhan Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins Circ Res 107 2010 1170 1184
8. D. Huang, E.A. Swanson, C.P. Lin, J.S. Schuman, W.G. Stinson, and W. Chang Optical coherence tomography Science 254 1991 1178 1181
9. I.K. Jang, B.E. Bouma, D.H. Kang, S.J. Park, S.W. Park, K.B. Seung, K.B. Choi, M. Shishkov, K. Schlendorf, E. Pomerantsev, S.L. Houser, H.T. Aretz, and G.J. Tearney Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound J Am Coll Cardiol 39 2002 604 609
10. S.H. Yun, G.J. Tearney, B.J. Vakoc, M. Shishkov, W.Y. Oh, A.E. Desjardins, M.J. Suter, R.C. Chan, J.A. Evans, I.K. Jang, N.S. Nishioka, J.F. de Boer, and B.E. Bouma Comprehensive volumetric optical microscopy in vivo Nat Med 12 2006 1429 1433
11. G.J. Tearney, S. Waxman, M. Shishkov, B.J. Vakoc, M.J. Suter, M.I. Freilich, A.E. Desjardins, W.Y. Oh, L.A. Bartlett, M. Rosenberg, and B.E. Bouma Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging JACC Cardiovasc Imaging 1 2008 752 761
12. H. Kitabata, A. Tanaka, T. Kubo, S. Takarada, M. Kashiwagi, H. Tsujioka, H. Ikejima, A. Kuroi, H. Kataiwa, K. Ishibashi, K. Komukai, T. Tanimoto, Y. Ino, K. Hirata, N. Nakamura, M. Mizukoshi, T. Imanishi, and T. Akasaka Relation of microchannel structure identified by optical coherence tomography to plaque vulnerability in patients with coronary artery disease Am J Cardiol 105 2010 1673 1678
13. G.J. Tearney, E. Regar, T. Akasaka, T. Adriaenssens, P. Barlis, H.G. Bezerra, B. Bouma, N. Bruining, J.M. Cho, S. Chowdhary, M.A. Costa, R. de Silva, J. Dijkstra, C. Di Mario, D. Dudek, E. Falk, M.D. Feldman, P. Fitzgerald, H.M. Garcia-Garcia, N. Gonzalo, J.F. Granada, G. Guagliumi, N.R. Holm, Y. Honda, F. Ikeno, M. Kawasaki, J. Kochman, L. Koltowski, T. Kubo, T. Kume, H. Kyono, C.C. Lam, G. Lamouche, D.P. Lee, M.B. Leon, A. Maehara, O. Manfrini, G.S. Mintz, K. Mizuno, M.A. Morel, S. Nadkarni, H. Okura, H. Otake, A. Pietrasik, F. Prati, L. Räber, M.D. Radu, J. Rieber, M. Riga, A. Rollins, M. Rosenberg, V. Sirbu, P.W. Serruys, K. Shimada, T. Shinke, J. Shite, E. Siegel, S. Sonoda, M. Suter, S. Takarada, A. Tanaka, M. Terashima, T. Thim, S. Uemura, G.J. Ughi, H.M. van Beusekom, A.F. van der Steen, G.A. van Es, G. van Soest, R. Virmani, S. Waxman, N.J. Weissman, G. Weisz International Working Group for Intravascular Optical Coherence Tomography (IWG-IVOCT) Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation J Am Coll Cardiol 59 2012 1058 1072
14. H. Yabushita, B.E. Bouma, S.L. Houser, H.T. Aretz, I.K. Jang, K.H. Schlendorf, C.R. Kauffman, M. Shishkov, D.H. Kang, E.F. Halpern, and G.J. Tearney Characterization of human atherosclerosis by optical coherence tomography Circulation 106 2002 1640 1645
15. K. Kato, T. Yonetsu, S.J. Kim, L. Xing, H. Lee, I. McNulty, R.W. Yeh, R. Sakhuja, S. Zhang, S. Uemura, B. Yu, K. Mizuno, and I.K. Jang Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study Circ Cardiovasc Imaging 5 2012 433 440
16. J. Narula, M. Nakano, R. Virmani, F.D. Kolodgie, R. Petersen, R. Newcomb, S. Malik, V. Fuster, and A.V. Finn Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques J Am Coll Cardiol 61 2013 1041 1051
17. M. Weis, C. Heeschen, A.J. Glassford, and J.P. Cooke Statins have biphasic effects on angiogenesis Circulation 105 2002 739 745
18. C. Urbich, E. Dernbach, A.M. Zeiher, and S. Dimmeler Double-edged role of statins in angiogenesis signaling Circ Res 90 2002 737 744
19. V. Fuster, P.R. Moreno, Z.A. Fayad, R. Corti, and J.J. Badimon Atherothrombosis and high-risk plaque: part I: evolving concepts J Am Coll Cardiol 46 2005 937 954
20. E. Falk, M. Nakano, J.F. Bentzon, A.V. Finn, and R. Virmani Update on acute coronary syndromes: the pathologists' view Eur Heart J 34 2013 719 728
21. S.S. Silvera, H.E. Aidi, J.H. Rudd, V. Mani, L. Yang, M. Farkouh, V. Fuster, and Z.A. Fayad Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries Atherosclerosis 207 2009 139 143
22. O.C. Raffel, G.J. Tearney, D.D. Gauthier, E.F. Halpern, B.E. Bouma, and I.K. Jang Relationship between a systemic inflammatory marker, plaque inflammation, and plaque characteristics determined by intravascular optical coherence tomography Arterioscler Thromb Vasc Biol 27 2007 1820 1827
23. N.R. Desai, R.P. Giugliano, J. Zhou, P. Kohli, R. Somaratne, E. Hoffman, T. Liu, R. Scott, S.M. Wasserman, and M.S. Sabatine AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57) J Am Coll Cardiol 63 2014 430 433
24. N.R. Desai, P. Kohli, R.P. Giugliano, M.L. O'Donoghue, R. Somaratne, J. Zhou, E.B. Hoffman, F. Huang, W.J. Rogers, S.M. Wasserman, R. Scott, and M.S. Sabatine AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C Assessment with Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined with Statin Therapy (LAPLACE)-Thrombolysis in Myocardial Infarction (TIMI) 57 trial Circulation 128 2013 962 969
25. N.J. Stone, J. Robinson, A.H. Lichtenstein, C.N. Bairey Merz, D.M. Lloyd-Jones, C.B. Blum, P. McBride, R.H. Eckel, J.S. Schwartz, A.C. Goldberg, S.T. Shero, D. Gordon, S.C. Smith Jr., D. Levy, K. Watson, and P.W. Wilson 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 2013 S0735 S1097